日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

TMEM132D and VIPR2 Polymorphisms as Genetic Risk Loci for Retinal Detachment: A Genome-Wide Association Study and Polygenic Risk Score Analysis

TMEM132D 和 VIPR2 多态性作为视网膜脱离的遗传风险位点:一项全基因组关联研究和多基因风险评分分析

Chuang, Hao-Kai; Hsieh, Ai-Ru; Ang, Tien-Yap; Chen, Szu-Wen; Yang, Yi-Ping; Huang, Hung-Juei; Chiou, Shih-Hwa; Lin, Tai-Chi; Chen, Shih-Jen; Hsu, Chih-Chien; Hwang, De-Kuang

Identification of VIPR2 rare and common variants in the Chinese Han population with schizophrenia

鉴定中国汉族精神分裂症患者中VIPR2的罕见和常见变异

Yin, Jiajun; Zhou, Juan; Fang, Fang; Yu, Shui; Wang, Jun; Yuan, Jianmin; Zhou, Zhenhe

The VIPR2-selective antagonist KS-133 changes macrophage polarization and exerts potent anti-tumor effects as a single agent and in combination with an anti-PD-1 antibody

VIPR2选择性拮抗剂KS-133可改变巨噬细胞极化,并作为单一药物或与抗PD-1抗体联合使用时发挥强效抗肿瘤作用。

Kotaro Sakamoto ,Wararat Kittikulsuth ,Eijiro Miyako ,Akumwami Steeve ,Rika Ishimura ,Shinsaku Nakagawa ,Yukio Ago ,Akira Nishiyama

Probing the VIPR2 Microduplication Linkage to Schizophrenia in Animal and Cellular Models

在动物和细胞模型中探究VIPR2微重复与精神分裂症的关联

Ago, Yukio; Asano, Satoshi; Hashimoto, Hitoshi; Waschek, James A

A 3' UTR SNP rs885863, a cis-eQTL for the circadian gene VIPR2 and lincRNA 689, is associated with opioid addiction

位于 3' UTR 的 SNP rs885863,是昼夜节律基因 VIPR2 和 lincRNA 689 的顺式 eQTL,与阿片类药物成瘾相关。

Levran, Orna; Randesi, Matthew; Rotrosen, John; Ott, Jurg; Adelson, Miriam; Kreek, Mary Jeanne

CFH and VIPR2 as susceptibility loci in choroidal thickness and pachychoroid disease central serous chorioretinopathy

CFH 和 VIPR2 是脉络膜增厚和厚脉络膜疾病(中心性浆液性脉络膜视网膜病变)的易感基因位点

Hosoda, Yoshikatsu; Yoshikawa, Munemitsu; Miyake, Masahiro; Tabara, Yasuharu; Ahn, Jeeyun; Woo, Se Joon; Honda, Shigeru; Sakurada, Yoichi; Shiragami, Chieko; Nakanishi, Hideo; Oishi, Akio; Ooto, Sotaro; Miki, Akiko; Iida, Tomohiro; Iijima, Hiroyuki; Nakamura, Makoto; Khor, Chiea Chuen; Wong, Tien Yin; Song, Kyuyoung; Park, Kyu Hyung; Yamada, Ryo; Matsuda, Fumihiko; Tsujikawa, Akitaka; Yamashiro, Kenji

Anti-AMPA GluA3 antibodies in Frontotemporal dementia: a new molecular target

额颞叶痴呆症中的抗 AMPA GluA3 抗体:一种新的分子靶点

B Borroni, J Stanic, C Verpelli, M Mellone, E Bonomi, A Alberici, P Bernasconi, L Culotta, E Zianni, S Archetti, M Manes, S Gazzina, R Ghidoni, L Benussi, C Stuani, M Di Luca, C Sala, E Buratti, A Padovani, F Gardoni

Impaired extinction of cued fear memory and abnormal dendritic morphology in the prelimbic and infralimbic cortices in VPAC2 receptor (VIPR2)-deficient mice

VPAC2受体(VIPR2)缺陷小鼠的前边缘皮层和下边缘皮层中,线索恐惧记忆消退受损,树突形态异常。

Ago, Yukio; Hayata-Takano, Atsuko; Kawanai, Takuya; Yamauchi, Ryosuke; Takeuchi, Shuto; Cushman, Jesse D; Rajbhandari, Abha K; Fanselow, Michael S; Hashimoto, Hitoshi; Waschek, James A

Methylomic analysis of salivary DNA in childhood ADHD identifies altered DNA methylation in VIPR2

对儿童注意力缺陷多动症患者唾液DNA的甲基化组学分析发现VIPR2基因的DNA甲基化发生改变

Wilmot, Beth; Fry, Rebecca; Smeester, Lisa; Musser, Erica D; Mill, Jonathan; Nigg, Joel T

Reductions in synaptic proteins and selective alteration of prepulse inhibition in male C57BL/6 mice after postnatal administration of a VIP receptor (VIPR2) agonist

出生后给予VIP受体(VIPR2)激动剂后,雄性C57BL/6小鼠突触蛋白减少,预脉冲抑制发生选择性改变

Ago, Yukio; Condro, Michael C; Tan, Yossan-Var; Ghiani, Cristina A; Colwell, Christopher S; Cushman, Jesse D; Fanselow, Michael S; Hashimoto, Hitoshi; Waschek, James A